← Open Payments lookup

SHELDON BROWN: Open Payments

NPI 1972985273 · DUBLIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$315 in 13 payments from 8 companies in 2025. Trend: 2023 $348 · 2024 $249 · 2025 $315

Food & beverage: $315
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.3$96
ABBVIE INC.2$50
E.R. Squibb & Sons, L.L.C.2$46
Otsuka America Pharmaceutical, Inc.2$37
HARMONY BIOSCIENCES LLC1$33
Supernus Pharmaceuticals, Inc.1$20
Lundbeck LLC1$18
Noven Therapeutics, LLC1$16

Products named: INGREZZA, VRAYLAR, COBENFY, REXULTI, WAKIX, Qelbree, ABILIFY ASIMTUFII, Xelstrym.

Industry payments across GA — which companies pay providers there.